Authors: Papoutsi, M Siemeister, G Weindel, K Tomarev, SI Kurz, H Schachtele, C Martiny-Baron, G Christ, B Marme, D Wilting, J

Citation: M. Papoutsi et al., Active interaction of human A375 melanoma cells with the lymphatics in vivo, HISTOCHEM C, 114(5), 2000, pp. 373-385

Authors: Schlaeppi, JM Siemeister, G Weindel, K Schnell, C Wood, J

Citation: Jm. Schlaeppi et al., Characterization of a new potent, in vivo neutralizing monoclonal antibodyto human vascular endothelial growth factor, J CANC RES, 125(6), 1999, pp. 336-342

Authors: Siemeister, G Schirner, M Weindel, K Reusch, P Menrad, A Marme, D Martiny-Baron, G

Citation: G. Siemeister et al., Two independent mechanisms essential for tumor angiogenesis: Inhibition ofhuman melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway, CANCER RES, 59(13), 1999, pp. 3185-3191

Authors: Kraft, A Weindel, K Ochs, A Marth, C Zmija, J Schumacher, P Unger, C Marme, D Gastl, G

Citation: A. Kraft et al., Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease, CANCER, 85(1), 1999, pp. 178-187

Authors: Ouyang, W Ranganath, SH Weindel, K Bhattacharya, D Murphy, TL Sha, WC Murphy, KM

Citation: W. Ouyang et al., Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism, IMMUNITY, 9(5), 1998, pp. 745-755